About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

1 1 (February 12, 2019)

handle is hein.crs/govxzc0001 and id is 1 raw text is: Congressional Research Service Informi ig the legislative debate since 1914 Updated February 12, 2019 Congressionally Directed Medical Research Programs Funding for FY2019 Members of Congress are frequently lobbied to add funding to annual defense appropriation legislation for certain medical research programs on a wide variety of diseases and topics. In addressing annual appropriations bills, many Members frequently seek information on enacted levels for such funding under the Congressionally Directed Medical Research Programs (CDMRP). CDMRP Administration and Funding The CDMRP is a congressional appropriation to the Department of Defense (DOD) explicitly for biomedical research in specific, congressionally identified health matters. The U.S. Army Medical Research and Materiel Command (USAMRMC) administers the CDMRP and is responsible for awarding and managing competitive grants. Congress usually inserts CDMRP funding as Undistributed Medical Research in the Defense Health Program's Research, Development, Test, and Evaluation (RDT&E) account in the annual DOD appropriation. CDMRP funding is not part of the President's budget request for overall RDT&E. Congressional documents accompanying the annual defense appropriation act (i.e., conference reports or explanatory statements) identify the specific research areas. The Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245), inserted $1.47 billion into the RDT&E account for CDMRP. This amount comprised 67% of the overall Defense Health Program's RDT&E appropriation, as indicated in Figure 1. Biomedical research conducted by the Defense Advanced Research Projects Agency or other military research agencies is not reflected in this account. Figure I. Total Defense Health Program RDT&E Appropriation, FY2019 'nVtions) Source: U.S. Congress, Conference Committee, conference report to accompany H.R. 6157, I I5th Cong., H.Rept. 115-952, p. 446. Funding amounts for specific medical research areas are listed in Table 1. Table I. CDMRP Funding, FY2019 (in millions of dollars) Program Title Alcohol and Substance Abuse Disorders Alzheimer's Disease Amyotrophic Lateral Sclerosis Autism Bone Marrow Failure Breast Cancer Chronic Pain Management Combat Readiness Duchenne Muscular Dystrophy Epilepsy Global HIV/AIDS prevention Gulf War Illness Hearing Restoration HIV/AIDS Joint Warfighter Medical Kidney Cancer Lung Cancer Lupus Melanoma Multiple Sclerosis Orthotics and Prosthetics Outcomes Ovarian Cancer Peer-Reviewed Cancer Peer-Reviewed Medical Peer-Reviewed Orthopedic Prostate Cancer Psychological Health/Traumatic Brain Injury Reconstructive Transplant Spinal Cord Injury Tick-Borne Disease Trauma Clinical Tuberous Sclerosis Vision Core Program Funding FY2019 4 15 10 7.5 3 130 10 15 3.2 7.5 8 22 10 12.9 50 20 14 5 10 6 10 20 90 350 30 100 125 12 30 5 10 6 20 299.2 TOTAL 1,470.3 Source: U.S. Congress, Conference Committee, conference report to accompany H.R. 6157, 1 15th Cong., H.Rept. 115-952, p.448. 0

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Purchase Access

Already a HeinOnline Subscriber?

Log In

profiles profiles most